For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the arrival of this treatment and the formulated version represents a significant breakthrough . These innovative therapies preserve the transthyretin protein, halting its damaging build-up and lessening the burden of the disease . People are now reporting p